What happenedShares of Marinus Pharmaceuticals Inc. (NASDAQ:MRNS), a clinical-stage biopharmaceutical company, are sliding in response to an upcoming secondary offering. In October, the company told shareholders it had enough cash on hand to fund operations into 2020; disappointed investors have pushed the stock 17.1% lower as of 3:48 p.m. EST...
What happenedShares of offshore oil and gas drilling-rig operators fell by double digits across the board in November, with share declines of at least 15% for all the major players in the space, according to data from S&P Global Market Intelligence. These included Transocean (NYSE:RIG) and Noble Corp. (NYSE:NE), which...
Every day, Wall Street analysts upgrade some stocks, downgrade others, and "initiate coverage" on a few more. But do these analysts even know what they're talking about? Today, we're taking one high-profile Wall Street pick and putting it under the microscope...It was a story as old as October. Much like...
What happenedShares of the world's largest oil-field services company, Schlumberger (NYSE:SLB), fell 12.1% in November, according to data provided by S&P Global Market Intelligence. That was relatively consistent with the overall oil-field services industry, as measured by the SPDR Oil & Gas Equipment and Services ETF, which fell 12.7% for the month. Schlumberger's...
It's no secret that money is a major source of contention in many relationships, so much so that it's currently a leading cause of divorce. But while many U.S. adults might turn to their partners to help pay the bills or provide a dose of much-needed financial security, they're...
Coming into this week's report, investors were optimistic that Dave & Buster's (NASDAQ:PLAY) would show continued progress in its business turnaround. Sales growth trends took a big step toward positive territory last quarter, after all, and the company paired that good news with a nice bump in profitability.On Tuesday,...
What happenedAfter it released disappointing pipeline news, shares of Neurocrine Biosciences (NASDAQ:NBIX), a commercial-stage biopharma focused on neurological and endocrine disorders, dropped 20% as of 10:34 a.m. EST on Wednesday.  So what Neurocrine announced top-line results from its Phase 2b T-Force GOLD study today. This trial tested its drug Ingrezza (which is also called...
Image source: The Motley Fool. Vera Bradley Inc  (NASDAQ:VRA)Q3 2019 Earnings Conference CallDec. 12, 2018, 9:30 a.m. ET Contents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks: Operator Good day, ladies and gentlemen, welcome to the Vera Bradley Third Quarter Fiscal 2019 Earnings Call. Today's conference is being recorded. At this time, I would like to turn...
What happenedShares of New Age Beverages (NASDAQ:NBEV), a maker of cannabidiol (CBD) beverages, were moving higher for the third day in a row today after the Farm Bill that would legalize hemp passed the Senate, taking another step to becoming law. The bill will now go to the House, where it's...
In the latest edition of the Industry Focus: Financials Between Two Fools interview series, Wofford Finance Professor Philip Swicegood discusses his unique approach to teaching college students about investing. And host Jason Moser and Fool.com contributor Matt Frankel, CFP, discuss the recent stock market volatility, what it means for...